0000000000299274

AUTHOR

Sarai Palanca

showing 2 related works from this author

Development of primary human NSCLC patient derived xenograft and organoids models as a precision approach to tumor treatment

2018

Oncologymedicine.medical_specialtyOncologybusiness.industryInternal medicineOrganoidMedicineTumor therapyHematologybusinessTumor xenograft
researchProduct

Pretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st…

2019

business.industryPcr assayHematologymedicine.diseaseEGFR Tyrosine Kinase Inhibitorslaw.inventionT790MOncologylawMutation (genetic algorithm)medicineCancer researchNon small lung cancerMutation detectionLung cancerbusinessPolymerase chain reactionAnnals of Oncology
researchProduct